ライフサイエンスコーパス: conjunctival

1 Conjunctival allergen provocation test (CAPT) reproduces

2 Conjunctival amyloidosis is a rare entity that may be ov

3 Conjunctival and bronchial provocation tests were perfor

4 of both serum samples were also compared on conjunctival and corneal cell cultures.

5 n addition, no differences were found on the conjunctival and corneal cells proliferation and differe

6 valuated using the OSDI questionnaire, TBUT, conjunctival and corneal staining, Schirmer test results

7 assessed in parallel for symptoms and signs (conjunctival and corneal staining, tear film break-up ti

8 Diagnoses included conjunctival and eyelid cutaneous melanoma (85 and 42 pa

9 The clinical diagnosis of conjunctival and eyelid margin tumors is challenging, an

10 the application of this technique applied to conjunctival and gut microbiome metagenomics sequencing

11 Despite negative conjunctival and musculocutaneous biopsy results, the po

12 Conjunctival and oral/pharyngeal lesions with subepithel

13 Twelve signs (6 corneal, 3 conjunctival, and 3 eyelid) were evaluated to obtain the

14 s and allergenic pollens and having a unique conjunctival associated lymphoid tissue.

15 tic review of the effectiveness and risks of conjunctival autograft (CAG) compared with amniotic memb

16 Fashioning and repositioning of the conjunctival autograft (flap time) was significantly sho

17 aluate the outcome of pterygium surgery with conjunctival autograft using Vicryl sutures (Ethicon, NJ

18 Patients undergoing pterygium surgery with conjunctival autografting were randomized into groups re

19 Tisseel fibrin glue for the repositioning of conjunctival autografts in pterygium surgery was associa

20 ldlife disease system, house finches and the conjunctival bacterial pathogen Mycoplasma gallisepticum

21 tation signifies the usually small number of conjunctival basal dendritic melanocytes that synthesize

22 Perilesional conjunctival biopsies are associated with an increase in

23 Patients who had conjunctival biopsies were more likely to have a negativ

24 Thirty-six patients who underwent a conjunctival biopsy for suspected MMP were included.

25 Conjunctival biopsy locations were defined as "lesional,

26 Conjunctival biopsy was taken and the location of the bi

27 re reviewed to determine the location of the conjunctival biopsy.

28 risk-factors for fibrosis and failure of the conjunctival bleb, further studies are required to explo

29 ow (Cypass microstent and iStent Supra), and conjunctival bleb-forming procedures (Xen gel stent and

30 (15 %) had HIV retinopathy and 7 (15 %) had conjunctival carcinoma.

31 We evaluated the outcomes and management of conjunctival carcinomas defined as <=0.2 mm invasion of

32 g SOD, promoting and maintaining corneal and conjunctival cell growth and integrity.

33 h photoabsorbance testing was used to assess conjunctival cell viability.

34 NP were assessed in mice primary corneal and conjunctival cells in vitro and in a DE murine model in

35 Cultured conjunctival cells respond to cytokines and inflammatory

36 Testing of cultured conjunctival cells revealed an increase in the levels of

37 We also examined the conjunctival challenge route to mimic the natural histor

38 was positive in 95% of bronchial and 90% of conjunctival challenges in cases, and negative in all co

39 d to explore the effect, if any, of post-TCP conjunctival changes on future bleb morphology and survi

40 ation findings included palpable mass (2/8), conjunctival chemosis (2/8), hyperglobus (1/8), hypoglob

41 dings included eyelid swelling and erythema, conjunctival chemosis, pain on eye movement, minimal dip

42 Key features were conjunctival ciliary injection and mutton fat keratic pr

43 sh over the AGV-FP7 plate immediately before conjunctival closure.

44 Conjunctival congestion persisted in 44% (11/25) in the

45 chirmer test, tear film breakup time (TBUT), conjunctival congestion, corneal haze, vascularization,

46 rtion of conjunctival injection (P = 0.003), conjunctival corkscrew vessels (P < 0.001), corneal scar

47 at the larger nanoparticles were "gulped" in conjunctival, corneal, retinal, and scleral cells, simil

48 served for corneal (days 28, 56, and 84) and conjunctival (days 56 and 84) staining.

49 The primary morbidity of anterior surface conjunctival disorders that include allergic conjunctivi

50 , injection location (superior or inferior), conjunctival displacement, use of provider gloves, use o

51 post-operatively and a case of limbal-based conjunctival dissection during open revision which lead

52 a of VKC patients and assess their levels in conjunctival epithelial and fibroblast cultures exposed

53 A miR microarray performed in primary human conjunctival epithelial cells (PECs) demonstrated signif

54 Conjunctival epithelial cells and fibroblasts were cultu

55 ich in turn was less than the size of limbal conjunctival epithelial defect (7.3+/-5.1 clock hours, P

56 e used to determine the extent of any limbal conjunctival epithelial defect and ischemia.

57 It is composed of rabbit conjunctival epithelium and lacrimal gland cell spheroid

58 vity of the molecular chaperone BiP/GRP78 in conjunctival epithelium of patients with ocular cicatric

59 he vessel density at three different depths: conjunctival epithelium or CAG epithelium, conjunctival

60 luid was collected from inferior fornix, and conjunctival epithelium was obtained by impression cytol

61 There were 2 incidents of conjunctival erosion and 1 inferotemporal macula-on reti

62 risks of complications such as hypotony and conjunctival erosion.

63 Conjunctival erythema, redness and edema of the eyelid a

64 Pterygia, defined as conjunctival extensions onto the clear cornea, were diag

65 lated 10 primary fibrotic and 7 non-fibrotic conjunctival fibroblast cell lines from patients with an

66 roblasts to disease progression, we isolated conjunctival fibroblasts from patients with scarring tra

67 Cultured human conjunctival fibroblasts were incubated in phosphate-buf

68 pare the clinical phenotype of patients with conjunctival fibrosis after glaucoma surgery with candid

69 markers of disease severity and prognosis in conjunctival fibrosis after glaucoma surgery.

70 Increased conjunctival fibrosis was evident in MP-TCP or CW-TCP-tr

71 for novel and more targeted means to control conjunctival fibrosis without such limitations has broug

72 6- as a potential contributor to the chronic conjunctival fibrosis, mediating reciprocal pro-fibrotic

73 st genome-wide RNA-Sequencing study in human conjunctival fibrosis.

74 on-viral delivery system for MRTF-B siRNA in conjunctival fibrosis.

75 being used as an initial procedure prior to conjunctival filtration surgeries.

76 or IOP control was observed in both types of conjunctival flap incisions.

77 re effectiveness of fornix- and limbal-based conjunctival flaps in trabeculectomy surgery.

78 etween visual outcome at 3 months and limbal conjunctival fluorescein staining (r = 0.67, P = .006),

79 We collected and tested axillary, blood, conjunctival, forehead, mouth, rectal, semen, urine, and

80 C57BL/6J mice received weekly periocular conjunctival fornix injections of a dexamethasone-21-ace

81 Significant conjunctival GC loss occurs in both experimental dry eye

82 gan Intranasal Tear Neurostimulator (ITN) on conjunctival goblet cell (GC) degranulation.

83 on had significant positive correlation with conjunctival goblet cell density (r = 0.181, P = 0.03).

84 n of HC-HA/PTX3 preserved tear secretion and conjunctival goblet cell density and mitigated inflammat

85 lacrimal glands and significantly increasing conjunctival goblet cell density compared with a standar

86 ntified using enzyme-linked immunoassay, and conjunctival goblet cell density was counted after Perio

87 purpose was to evaluate the correlations of conjunctival goblet cell density with tear MUC5AC concen

88 Conjunctival goblet cell dysfunction and death are promo

89 ermine the actions of LXA4 on cultured human conjunctival goblet cell mucin secretion and increase in

90 the effectiveness of the ITN application on conjunctival goblet cell secretory response.

91 Under physiologic conditions, conjunctival goblet cells (CGCs) secrete mucins into the

92 We conclude that conjunctival goblet cells respond to LXA4 through the AL

93 Conjunctival goblet cells synthesize and secrete mucins

94 eye disease such as aqueous tear secretion, conjunctival goblet cells, epithelial corneal integrity,

95 llular [Ca(2+)] and stimulate secretion from conjunctival goblet cells.

96 ization or revascularization of conjunctiva, conjunctival graft and episclera, in a quantitative and

97 Complications included 5 cases of conjunctival graft dislocation in the Evicel group, 1 ca

98 Conjunctival hemodynamic descriptors, namely vessel diam

99 Quantitative assessment of conjunctival hemodynamics can potentially be useful for

100 ed in 76% of participants (16/21), including conjunctival hemorrhage (n = 5), retinal hemorrhage (n =

101 dence of 26%, 25%, and 1%, respectively, and conjunctival hemorrhage (typically petechial), with an i

102 66-years-old caucasian female complaining of conjunctival hemorrhage and chemosis in both eyes for th

103 uent AEs reported for the RTH258 groups were conjunctival hemorrhage, eye pain, and conjunctival hype

104 woman was referred with repeated episodes of conjunctival "hemorrhages" and chemosis with extended re

105 ut corneal or eyelid changes and mild bulbar conjunctival hyperaemia in a third of cases.

106 Biomicroscopy showed conjunctival hyperaemia in the left eye with a slight el

107 7 +/- 3.0 vs 327.7 +/- 5.1 mOsm/L, P = .03), conjunctival hyperemia (1.3 +/- 0.1 vs 1.6 +/- 0.1, P =

108 lar AE among netarsudil-treated patients was conjunctival hyperemia (47.9%), which was predominately

109 The most frequent ocular adverse event was conjunctival hyperemia (netarsudil/latanoprost FDC, 53.4

110 -6.2), hypotony (OR, 4.2; 95% CI, 1.3-13.6), conjunctival hyperemia (OR, 2.6; 95% CI, 1.02-6.5), and

111 sensation, tearing, foreign body sensation, conjunctival hyperemia and photophobia.

112 ll 3 AEs were generally scored as mild, with conjunctival hyperemia and/or hemorrhage appearing spora

113 Conjunctival hyperemia was the most common treatment-rel

114 Conjunctival hyperemia with onset later than 2 days afte

115 was significantly associated with hypotony, conjunctival hyperemia, and fibrinous reaction on presen

116 re: tear osmolarity, phenol red thread test, conjunctival hyperemia, fluorescein tear break-up time,

117 relative to the other eye: (1) ocular (e.g., conjunctival hyperemia, iris heterochromia, and buphthal

118 Conjunctival hyperemia, lip swelling, cold sweats, and n

119 The most common AE was conjunctival hyperemia, mostly of mild severity, with an

120 smolarity, Schirmer test, tear breakup time, conjunctival hyperemia, staining of the cornea and conju

121 Corneal and conjunctival staining, conjunctival hyperemia, tear film breakup time (TBUT), t

122 The most frequent adverse event was conjunctival hyperemia, the incidence of which ranged fr

123 ular, with the most frequent ocular AE being conjunctival hyperemia, with an incidence of 61%, 66%, a

124 were conjunctival hemorrhage, eye pain, and conjunctival hyperemia; the majority of these events wer

125 Limbus-based conjunctival incision had longer time to failure for pos

126 oups, but older patient age and limbus-based conjunctival incision were associated with significantly

127 lar topical medication to prevent gonococcal conjunctival infection in newborns.

128 to consistent dissemination to kidney after conjunctival infection was approximately 10(8) leptospir

129 nitiated during childhood following repeated conjunctival infection with Chlamydia trachomatis, which

130 15-treated mice showed significantly reduced conjunctival infiltration of Th17 cells and lower cornea

131 MP-TCP causes significantly greater overall conjunctival inflammation and scarring compared to contr

132 We observed greater conjunctival inflammation in MP-TCP or CW-TCP-treated ey

133 cular microbiomes had more severe MG-induced conjunctival inflammation than birds with unaltered micr

134 tic precipitates (22%), corneal edema (13%), conjunctival injection (10%), chemosis (4%), hypopyon (4

135 erpalpebral conjunctival melanosis (44%) and conjunctival injection (43%).

136 ategory 1, including a greater proportion of conjunctival injection (P = 0.003), conjunctival corkscr

137 manifested right eye (RE) excessive tearing, conjunctival injection and pain.

138 nilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and perhaps i

139 nilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-las

140 Rash was present in 30 of 58 (52%), and conjunctival injection in 26 of 58 (45%) cases.

141 elayed presentation were more likely to have conjunctival injection on initial examination (delayed,

142 rointestinal symptoms, 60% had rash, 56% had conjunctival injection, and 27% had mucosal changes.

143 macular or maculopapular rash, arthralgias, conjunctival injection, and headache; 27% had fever (sho

144 nced coughing, nasal drop, eyelid edema, and conjunctival injection.

145 adnexa, diplopia, superficial corneal and/or conjunctival injuries, and orbital fractures accounted f

146 term because it does not distinguish between conjunctival intraepithelial melanin overproduction ("hy

147 Comparison of conjunctival intraepithelial neoplasia (CIN) vs SCC reve

148 as squamous (2 benign papillomas, 2 grade 2 conjunctival intraepithelial neoplasias, 7 in situ squam

149 in staining (r = 0.67, P = .006), and limbal conjunctival ischemia on OCTA (r = 0.76, P = .001).

150 Twenty-five patients with an untreated conjunctival lesion (5 melanoma, 13 nevus, 7 primary acq

151 ay be challenging, as tumors mimic a primary conjunctival lesion.

152 Good OCTA images were obtained in 18 of 25 conjunctival lesions and 42 of 52 iris lesions.

153 In all imaged conjunctival lesions and 77% of iris lesions, vascular s

154 n-invasive tool, useful in the evaluation of conjunctival lesions and planning surgery.

155 and presented to our service with suspicious conjunctival lesions at a median of 22 years later (mean

156 Conjunctival lesions may lead to impaired vision and, fi

157 Conjunctival lesions were diagnosed with a conventional

158 Conjunctival lesions were excised in toto using a standa

159 years), a total of 166 eyelid margin and 129 conjunctival lesions were included in the analysis.

160 8 consecutive patients with eyelid margin or conjunctival lesions were included.

161 ex vivo preliminary diagnosis of suspicious conjunctival lesions with good histologic details and ma

162 sional biopsies for diagnosing indeterminate conjunctival lesions.

163 isional biopsies in diagnosing indeterminate conjunctival lesions; and its association with cardiac m

164 break-up time, corneal fluorescein staining, conjunctival lissamine green staining, and Schirmer test

165 We report a case of conjunctival lymphangiectasia in which anterior segment

166 Conjunctival lymphangiectasia is a rare condition presum

167 nical appearance we suspected the case to be conjunctival lymphangiectasia or lymphangioma.

168 munhistochemistry confirmed the diagnosis of conjunctival lymphangiectasia.

169 hannels or by an abnormal connection between conjunctival lymphatic and blood vessels.

170 clinical features of the various subtypes of conjunctival lymphoma (CL) have not been previously eval

171 Conjunctival lymphoma commonly manifested in elderly ind

172 Conjunctival lymphoma consists of mainly 4 subtypes of B

173 To present a case of conjunctival lymphoma in a young woman complicated by pr

174 Partial regrowth of conjunctival lymphoma occurred 6 months after excision a

175 fferentiated from chronic conjunctivitis and conjunctival malignancies.

176 mising procedure in patients with eyelid and conjunctival malignancy, and it is useful in identifying

177 6/22 (27%) never took conjunctival mapping biopsies and 12/23 (52%) never scre

178 ent of the peripheral and deep tissue edges; conjunctival mapping biopsies can facilitate surgical pl

179 ommercially available HR-OCT to identify the conjunctival margins of the neoplastic lesion.

180 VA-induced allergic response, the numbers of conjunctival mast cells were lower in CCL7-deficient mic

181 All pre- and postoperative biopsies of flat conjunctival melanocytic disorders should be evaluated i

182 Pathologic diagnoses were low-grade conjunctival melanocytic intraepithelial lesion (n = 18,

183 stochemical stains resulted in an upgrade of conjunctival melanocytic intraepithelial lesion from low

184 ithelial lesion (n = 18, 38%) and high-grade conjunctival melanocytic intraepithelial lesion/melanoma

185 itations of the 3 classification systems for conjunctival melanocytic intraepithelial lesions and sug

186 ost commonly used classification systems for conjunctival melanocytic intraepithelial lesions with th

187 a, and the WHO 4th edition classification of conjunctival melanocytic intraepithelial lesions.

188 and 2018 were searched for all patients with conjunctival melanocytic intraepithelial lesions.

189 slides using 3 classification systems: PAM, conjunctival melanocytic intraepithelial neoplasia, and

190 high-grade lesions was 76% for PAM, 67% for conjunctival melanocytic intraepithelial neoplasia, and

191 hirty-one patients underwent 47 biopsies for conjunctival melanocytic lesions between 2014 and 2018.

192 Conjunctival melanoma (CM) is a highly aggressive ocular

193 Conjunctival melanoma and nevi demonstrated the same int

194 mplanted after resection with cryotherapy: 5 conjunctival melanoma, 4 squamous cell carcinoma, 1 seba

195 and ocular surface, including interpalpebral conjunctival melanosis (44%) and conjunctival injection

196 This, together with conjunctival membranes and subconjunctival hemorrhage, w

197 es, even after accounting for differences in conjunctival MG load.

198 The conjunctival microcirculation can be non-invasively imag

199 In this study, alterations in conjunctival microvascular hemodynamics were quantitativ

200 tive patients with histology-proven invasive conjunctival miSCC/SCC treated between 2002 and 2017.

201 ant depended upon the amount of scarring and conjunctival mobility.

202 Among cases of conjunctival mucosa-associated lymphoid tissue lymphoma,

203 e clinics, and direct contact with patients' conjunctival mucosal surfaces.

204 There were 28 patients with conjunctival myxoid lesions diagnosed as myxoma (16/28),

205 estigations in all patients who present with conjunctival myxoma (J Ophthalmol (1);1-5, 2014; Ophthal

206 This case of conjunctival myxoma adds to the small number of document

207 y to cardiac myxoma, thus early diagnosis of conjunctival myxoma can prevent potentially devastating

208 onal, multicenter study of all patients with conjunctival myxoma, conjunctival stromal tumor, or reac

209 under local anaesthesia and reported to be a conjunctival myxoma.

210 ion were consistent with previous reports on conjunctival myxoma:80-84, 1986).

211 nnot reliably distinguish between neoplastic conjunctival myxomas and other myxoid lesions, underscor

212 Conjunctival myxomas can occur in association with the C

213 ays a role in the development of a subset of conjunctival myxomas, particularly in tumors fulfilling

214 Conjunctival, nasal and throat swabs were collected from

215 iceal (3/4, 75%), or nasal (1/4, 25%) bulbar conjunctival nodules, which were asymptomatic (3/4, 75%)

216 ration, and conjunctivalization), history of conjunctival or lid surgery, and requirement for systemi

217 nt 83 primary excisions with cryotherapy for conjunctival PAM who had adequate tissue for histopathol

218 al moderate to severe upper and lower tarsal conjunctival papillary reaction, without corneal or eyel

219 who underwent a primary biopsy procedure for conjunctival primary acquired melanosis (PAM) at Wills E

220 ntropion (adjusted OR, 11.25; P = .003), and conjunctival prolapse (adjusted OR, 7.10; P = .03).

221 Efficacy was assessed by comparing conjunctival provocation test (CPT) reactions at baselin

222 Conjunctival provocation test (CPT) response thresholds

223 Conjunctival provocation tests (CPT) were performed befo

224 raocular pressures remained unchanged during conjunctival reconstruction and subsequent secondary tre

225 e objective and subjective quantification of conjunctival redness in images obtained with calibrated

226 Mild conjunctival retraction occurred in 4 eyes (8.9%) betwee

227 The conjunctival route resulted in a delay in the time to pe

228 using an enzootic mode of transmission, the conjunctival route.

229 doses of EBOV (Makona strain) by the oral or conjunctival routes.

230 ease severity as determined by the degree of conjunctival scarring (using Tauber staging), central co

231 Eleven showed progression of conjunctival scarring during a median follow-up of 42 mo

232 I, 1.31-7.70; P = 0.01) in PLTR and baseline conjunctival scarring in BLTR (OR, 1.72; 95% CI, 1.06-2.

233 in high for patients who have Foster stage 3 conjunctival scarring on presentation or worsening of sc

234 Conjunctival scarring score at presentation in both biop

235 significantly improved and finally turned to conjunctival scarring.

236 nce of epilation, in association with tarsal conjunctival scarring.

237 nce of epilation, in association with tarsal conjunctival scarring.

238 Five of 28 patients had mild tarsal conjunctival scarring.

239 ad limbal signs (pannus and/or HPs) plus any conjunctival scarring.

240 (2%) had limbal signs and moderate or severe conjunctival scarring.

241 Conjunctival scraping was carried out and the culture re

242 Viral RNA has been identified in tears and conjunctival secretions in patients with active conjunct

243 Corneal, eyelid, and conjunctival signs were evaluated and given scores rangi

244 ial cell expression was also seen in control conjunctival specimens.

245 A subset of ocular invasive conjunctival squamous carcinomas express high levels of

246 , corneal staining (1.4 vs 0.2, P < 0.0001), conjunctival staining (1.4 vs 0.3, P < 0.0001), and tear

247 0.59-1.51, for visit 2 and 3, respectively), conjunctival staining (mean, 0.95; 95% CI, 0.54-1.37 vs.

248 < 0.013), Schirmer test results (P < 0.001), conjunctival staining (P < 0.001), and corneal staining

249 18 mm; month 18, 52 +/- 10 mm, p < 0.0001), conjunctival staining (P = 0.04) and OSDI questionnaire

250 showed a consistent reduction in corneal and conjunctival staining compared with both vehicle and Res

251 P < 0.1, central corneal staining P < 0.001, conjunctival staining P < 0.01).

252 chirmer test, tear breakup time, corneal and conjunctival staining, and meibomian gland dysfunction,

253 Corneal and conjunctival staining, conjunctival hyperemia, tear film

254 p showed greater improvements in corneal and conjunctival staining, hyperemia, and TBUT than the PA g

255 , tear film breakup time (TBUT), corneal and conjunctival staining, meibomian grading, and Ocular Sur

256 ear break-up time, evaluation of corneal and conjunctival staining, Schirmer I test, Cochet-Bonnet es

257 and subregion corneal fluorescein staining, conjunctival staining, visual analog scale (VAS) for dry

258 the signs of DED, as measured by corneal and conjunctival staining.

259 1.57-2.33 vs. mean, 2.58; 95% CI, 2.17-2.98; conjunctival staining: mean, 1.68; 95% CI, 1.29-2.08 vs.

260 : conjunctival epithelium or CAG epithelium, conjunctival stroma or CAG stroma, and episclera, was ev

261 myxoid lesions diagnosed as myxoma (16/28), conjunctival stromal tumor (10/28), or reactive fibromyx

262 dy of all patients with conjunctival myxoma, conjunctival stromal tumor, or reactive fibromyxoid prol

263 , diagnosis of uveitis or dry eye, and prior conjunctival surgery were not correlated with the presen

264 escribes an incision-free minimally invasive conjunctival surgical (MICS) technique to repair late-on

265 swab plus Schirmer's test strips (group 1), conjunctival swab (group 2), and Schirmer's test strips

266 of laboratory confirmation using 3 methods: conjunctival swab plus Schirmer's test strips (group 1),

267 Conjunctival swab remains the gold standard of tear coll

268 Overall, conjunctival swabs are positive in 2.5%.

269 quantification of ZIKAV RNA was performed on conjunctival swabs collected from both eyes of these pat

270 V and the viral RNA copy numbers detected in conjunctival swabs ranged from 5.2 to 9.3 copies respect

271 examined for clinical signs of trachoma, and conjunctival swabs were collected for C. trachomatis det

272 Conjunctival swabs were collected from patients presenti

273 They were evaluated for clinical trachoma, conjunctival swabs were tested for chlamydial infection

274 d antibody testing: TF and TT were assessed, conjunctival swabs were tested for chlamydial infection,

275 In vivo, CCL7 was upregulated in conjunctival tissue during an OVA-induced allergic respo

276 ults support the need to sample perilesional conjunctival tissue in patients with suspected MMP.

277 ed with IgE-mediated mast cell activation in conjunctival tissue leading to the release of preformed

278 et leaking blebs without cutting or excising conjunctival tissue.

279 The IL6 and PRG4 protein expression in conjunctival tissues was also assessed using in situ imm

280 We characterized the conjunctival, tongue and fecal microbiome profiles of pa

281 rospective case series reviewed 806 cases of conjunctival tumor in children (aged <21 years) who were

282 A conjunctival tumor margin identified with the HR-OCT coi

283 Among the 806 patients with conjunctival tumor, the top 5 diagnoses included nevus (

284 lar uveal tumor spread rather than a primary conjunctival tumor.

285 74% vs 46%), but slightly less for malignant conjunctival tumors (78% vs 88%).

286 In an ocular oncology practice, conjunctival tumors are benign (52%), premalignant (18%)

287 To evaluate frequency of conjunctival tumors in all ages and compare benign vs ma

288 cular tertiary referral center, suggest that conjunctival tumors in children are nearly always benign

289 Conjunctival tumors in children are usually benign and r

290 To evaluate clinical features of conjunctival tumors in children by comparing benign tumo

291 Treatment of the conjunctival tumors included excisional biopsy (n = 4),

292 Overall, conjunctival tumors were benign (779 [97%]) or malignant

293 the main cause for misdiagnosis of malignant conjunctival tumors with IVCM.

294 elative frequency of any malignancy (per all conjunctival tumors) by age bracket (0-5 years, >5-10 ye

295 IVCM) for the diagnosis of eyelid margin and conjunctival tumors.

296 ful tool for the identification of malignant conjunctival tumors.

297 ntraoperative and postsurgical management of conjunctival tumors.

298 and corneal epithelial defects, 25%, 3 days; conjunctival ulceration, 39%, 3.5 days; symblepharon, 28

299 oma with no evidence of primary eyelid skin, conjunctival, uveal, or remote melanoma at extraocular s

300 twork of episclera was not affected, and the conjunctival vascularization was restored at 1 month.

301 Modulating conjunctival wound healing has the potential to improve